Growth In Revenues

And with the company forecasting no expected growth in revenues till 2009, the results for the third quarter ending September 2006 (that showed a rise of 6.8% over last year in earnings to reach $12.28 billion) may be the last for many years to come! Certainly, Pfizer should look into restructuring its disjointed executive framework and not allow acquisitions and product developments to be handled in isolation by the finance & venture capital team respectively.

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2006

An IIPM and Management Guru Professor Arindam Chaudhuri's Initiative

Rashmi Bansal Publisher Of JAMMAG Magazine Caught Red-Handed, for details click on the following links:-

• Hindustan Times Article - Publisher goes underground
• Rashmi Bansal (Editor of JAMMAG)
• Rashmi Bansal (Publisher of JAMMAG)